High-quality
real-world data
Generating high-validity real-world evidence requires high-quality RWD.
Accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas using credible evidence developed from high-quality real-world data with unrivaled richness and reliability.
High-quality
real-world data
Generating high-validity real-world evidence requires high-quality RWD.
Accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas using credible evidence developed from high-quality real-world data with unrivaled richness and reliability.
New times call for a powerful platform
For biopharma decision-makers, Verantos is making what seemed impossible, possible. Our high-validity RWE platform combines deep phenotyping — structured and unstructured data from electronic health records (EHR), artificial intelligence (AI), and accuracy determination — with linkage to exposure and outcomes data to answer today’s most challenging research questions.
Our Awards
Meet increasing RWE demands
High-validity RWE – generated from the entire patient record – makes it possible to understand how patient characteristics and behaviors affect health outcomes to predict the progression of a disease and a patient’s responses to therapy while also increasing the efficiency of R&D investments and accelerating time to market.
Get out of the danger zone
Studies based on traditional RWE leave franchises vulnerable to regulatory and market access concerns and commercial delay. High-validity studies run on our high-validity RWE platform provide accurate and believable evidence, enabling regulatory and reimbursement approvals. It is worth investing now in the RWE capabilities of the future.
Our products
Pragmatic Registry
Pragmatic Registry is a disease-specific registry of subjects generated from routinely collected, real-world data.
- Clinically rich data from the entire patient record incorporates variables that are rarely or never coded in structured data
- Measurable industry-leading data reliability enabling high-validity evidence generation facilitates clinical assertions to support clinician, payer, and regulator decision-making
- Registry data are normalized and delivered in standardized OMOP CDM format, ready for use.
Our Partners
